Immunologic and hemodynamic effects of "low-dose" hydrocortisone in septic shock - A double-blind, randomized, placebo-controlled, crossover study
Immunologic and hemodynamic effects of "low-dose" hydrocortisone in septic shock - A double-blind, randomized, placebo-controlled, crossover study
复制标题
DOI:
10.1164/rccm.200205-446oc
复制
发表时间:
2003-02-15
影响因子:
24.7
通讯作者:
Gerlach, H
中科院分区:
文献类型:
--
作者:
Keh, D;Boehnke, T;Gerlach, H
Within the last few years, increasing evidence of relative adrenal insufficiency in septic shock evoked a reassessment of hydrocortisone therapy. To evaluate the effects of hydrocortisone on the balance between proinflammatory and antiinflammation, 40 patients with septic shock were randomized in a double-blind crossover study to receive either the first 100 mg of hydrocortisone as a loading dose and 10 mg per hour until Day 3 (n = 20) or placebo (n = 20), followed by the opposite medication until Day 6. Hydrocortisone infusion induced an increase of mean arterial pressure, systemic vascular resistance, and a decline of heart rate, cardiac index, and norepinephrine requirement. A reduction of plasma nitrite/nitrate indicated inhibition of nitric oxide formation and correlated with a reduction of vasopressor support. The inflammatory response (interieukin-6 and interieukin-8), endothelial (soluble E-selectin) and neutrophil activation (expression of CD11 b, CD640, and antlinflammatory response (soluble tumor necrosis factor receptors I and II and interieukin-10) were attenuated. In peripheral blood monocytes, human leukocyte antigen-DR expression was only slightly depressed, whereas in vitro phagocytosis and the monocyte-activating cytokine interleukin-12 increased. Hydrocortisone withdrawal induced hemodynamic and immunologic rebound effects. In conclusion, hydrocortisone therapy restored hemodynamic stability and differentially modulated the immunologic response to stress in a way of antiinflammation rather than immunosuppression.